PTC Therapeutics | PTCT - Market Capitalization


PTC Therapeutics reported $5.02B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.06B 196M Jun/2026
Cytokinetics USD 11.55B 3.36B Jun/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 156.86B 16.13B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026
Ultragenyx Pharmaceutical USD 3.29B 1.23B Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026
Xencor USD 1.19B 301M Jun/2026